Skip to content

Care coordinator delivered method of levels for psychosis

Care coordinator delivered method of levels therapy to improve engagement and other outcomes in early psychosis (CAMEO): a feasibility cluster randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14082421
Enrollment
120
Registered
2022-04-29
Start date
2022-05-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-episode psychosis Mental and Behavioural Disorders Unspecified nonorganic psychosis

Interventions

The study uses a feasibility cluster randomised controlled trial (C-RCT) design with two parallel conditions: (1) treatment as usual (TAU) or (2) TAU plus support from a care coordinator who has recei

Sponsors

Greater Manchester Mental Health NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Early Intervention in Psychosis (EIP) team eligibility criteria: EIP teams operating within three participating NHS Trusts (Greater Manchester Mental Health [GMMH], Lancashire and South Cumbria NHS Foundation Trust [LSCFT], and Merseycare) will be included in the study when organisational support is provided for at least two care coordinators to engage with the MOL training and supervision. Care coordinator participant eligibility criteria: 1. Working within EIP services based within participating NHS Trusts 2. Likely to remain in their current post for the duration of the study 3. Have organisational support from their employer to engage with MOL training and supervision 4. Willing and able to engage with MOL training and supervision 5. Provide informed consent to participate in the study Service user participant eligibility criteria: 1. Current users of an EIP service that is included in the study 2. Have an allocated care coordinator who is participating in the study 3. Due to remain under the care of their EIP service until the end of the study 4. Have the capacity to provide informed consent to participate in the study 5. Have sufficient written and verbal English language skills to complete outcome measures and engage with the MOL intervention 6. Aged 18 years or older

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Feasibility of recruiting and retaining service user and care coordinator participants, assessed using the number of participants who consent to participate who remain in the study until the end of follow-up at 6 months

Secondary

MeasureTime frame
To help determine the most appropriate primary and secondary outcomes for a definitive trial, participants will be asked to complete a range of standardised outcome measures. Service user participants will be asked to complete the following measures at baseline, 3, and 6 months: 1. Personal recovery from psychosis measured using the Questionnaire about the Process of Recovery (QPR) 2. Quality of life and treatment satisfaction measured using DIALOG 3. Goal conflict reorganisation measured using the Reorganisation of Conflict Scale (ROC) 4. Quality of the therapeutic alliance between clinician and service-user measured using the Working Alliance Inventory-Short Revised (WAI-SR) 5. Health outcome (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) measured using EQ-5D-5L (EuroQol Group) 6. Use of health and social care services (including inpatient, outpatient, A&E, GP) during the study measured using the Resource Use Questionnaire (RUQ) Care coordinator participants will be asked to complete the following measure at baseline and 6 months: Burnout measured using the Maslach Burnout Inventory: Human Services Survey (MBI-HSS)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026